DOMETIC GP (DTCGF)
(Delayed Data from OTC)
$6.90 USD
0.00 (0.00%)
Updated Jun 12, 2024 09:30 AM ET
4-Sell of 5 4
C Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for DOMETIC GP falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,619 | 2,950 | 2,509 | 1,767 | 1,958 |
Cost Of Goods | 1,885 | 2,169 | 1,767 | 1,188 | 1,323 |
Gross Profit | 734 | 781 | 742 | 578 | 635 |
Selling & Adminstrative & Depr. & Amort Expenses | 481 | 505 | 409 | 373 | 387 |
Income After Depreciation & Amortization | 253 | 276 | 333 | 205 | 247 |
Non-Operating Income | 16 | 4 | 2 | 1 | 1 |
Interest Expense | 91 | 39 | 60 | 59 | 55 |
Pretax Income | 178 | 242 | 275 | 147 | 194 |
Income Taxes | 52 | 65 | 73 | 98 | 53 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 126 | 177 | 201 | 49 | 140 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 126 | 177 | 201 | 49 | 140 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 397 | 423 | 440 | 291 | 334 |
Depreciation & Amortization (Cash Flow) | 144 | 146 | 107 | 86 | 86 |
Income After Depreciation & Amortization | 253 | 276 | 333 | 205 | 247 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 319.42 | 319.50 | 309.60 | 295.80 | 295.80 |
Diluted EPS Before Non-Recurring Items | 0.56 | 0.83 | 0.65 | 0.17 | 0.47 |
Diluted Net EPS (GAAP) | 0.39 | 0.55 | 0.65 | 0.17 | 0.47 |
Fiscal Year end for DOMETIC GP falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 716.70 | 627.24 | 499.32 | 631.78 | 791.26 |
Cost Of Goods | NA | 452.53 | 364.30 | 439.10 | 569.53 |
Gross Profit | NA | 174.71 | 135.02 | 192.68 | 221.73 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 116.00 | 111.96 | 119.79 | 128.25 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 58.71 | 23.06 | 72.89 | 93.48 |
Non-Operating Income | NA | 1.92 | 8.26 | 4.44 | 2.09 |
Interest Expense | NA | 22.87 | 23.15 | 21.46 | 26.79 |
Pretax Income | NA | 37.67 | 7.79 | 55.87 | 68.88 |
Income Taxes | NA | 11.44 | 3.05 | 17.76 | 18.05 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 41.44 | 26.24 | 4.74 | 38.11 | 50.83 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 41.44 | 26.24 | 4.84 | 38.11 | 50.73 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 319.50 | 319.50 | 318.75 | 319.50 | 319.50 |
Diluted EPS Before Non-Recurring Items | 0.16 | 0.12 | 0.06 | 0.16 | 0.20 |
Diluted Net EPS (GAAP) | 0.13 | 0.08 | 0.02 | 0.12 | 0.16 |